ArticleJournal of oncology2022

Osimertinib Improves the Immune Microenvironment of Lung Cancer by Downregulating PD-L1 Expression of Vascular Endothelial Cells and Enhances the Antitumor Effect of Bevacizumab.

Xuejun Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.